SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-022644
Filing Date
2024-02-29
Accepted
2024-02-29 07:30:36
Documents
92
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K akro-20231231.htm   iXBRL 10-K 3448774
2 EX-23.1 akro-ex23_1.htm EX-23.1 3236
3 EX-31.1 akro-ex31_1.htm EX-31.1 16153
4 EX-31.2 akro-ex31_2.htm EX-31.2 15895
5 EX-32.1 akro-ex32_1.htm EX-32.1 13315
6 EX-97.1 akro-ex97_1.htm EX-97.1 38459
7 GRAPHIC img234530020_0.jpg GRAPHIC 148656
8 GRAPHIC img234530020_1.jpg GRAPHIC 16614
9 GRAPHIC img234530020_2.jpg GRAPHIC 20223
10 GRAPHIC img234530020_3.jpg GRAPHIC 330126
11 GRAPHIC img234530020_4.jpg GRAPHIC 205923
12 GRAPHIC img234530020_5.jpg GRAPHIC 241283
13 GRAPHIC img234530020_6.jpg GRAPHIC 87437
14 GRAPHIC img234530020_7.jpg GRAPHIC 200914
15 GRAPHIC img234530020_8.jpg GRAPHIC 156335
16 GRAPHIC img234530020_9.jpg GRAPHIC 66633
17 GRAPHIC img234530020_10.jpg GRAPHIC 119273
18 GRAPHIC img234530020_11.jpg GRAPHIC 108727
19 GRAPHIC img234530020_12.jpg GRAPHIC 174731
  Complete submission text file 0000950170-24-022644.txt   16522078

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT akro-20231231.xsd EX-101.SCH 1448217
93 EXTRACTED XBRL INSTANCE DOCUMENT akro-20231231_htm.xml XML 2276960
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38944 | Film No.: 24698888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)